|
Biomarker és fenotípus profil vizsgálata a terápiás válasszal összefüggésben major depressziós zavarban szenvedők körében
|
súgó
nyomtatás
|
Ezen az oldalon az NKFI Elektronikus Pályázatkezelő Rendszerében nyilvánosságra hozott projektjeit tekintheti meg.
vissza »
|
|
Közleményjegyzék |
|
|
Monika Elemery, Szilvia Kiss, Peter Dome, Laszlo Pogany, Gabor Faludi, Judit Lazary: Change of Circulating Vascular Endothelial Growth Factor Level and Reduction of Anhedonia Are Associated in Patients With Major Depressive Disorder Treated With Repetitiv, Frontiers in Psychiatry, 2022 | Elemery Monika, Kiss Szilvia, Gonda Xenia, Döme Péter, Lazáry Judit: Vascular endothelial growth factor (VEGF) as a potential biomarker in major dipressive disorder, Neuropsychopharmacologia Hungarica, 2017 | Lazáry Judit: From stone-craved genes to Michelangelo: significance and different aspects of gene-environment interaction, Neuropsychopharmacologia Hungarica, 2017 | Csala Irén, Döme Péter, Lazáry Judit: Maternal bonding style, cholinergic receptor gene polymorphisms in association with smoking-related depressive symptoms, Neuropsychopharmacologia Hungarica, 2017 | Lazáry Judit, Eszlári Nóra, Juhász Gabriella, Bagdy György: Genetic association analyses of the endocannabinoid system on anxious phenotype, http://www.mppt.hu/images/magazin/pdf/xix-evfolyam-4-szam/lazary_eredeti_honlapra.pdf, 2017 | Lazáry Judit: Stress, inflammation and depression: integrative role of endocannbinoid pathway, European Psychiatry, 2018 | Lazary Judit: Highlights of peripheral biomarkers in major depressive disorder: focus on HPA-axis, inflammation and neurotrophic factors, pubmed, 2018 | Dome P, Tombor L, Lazary J, Gonda X, Rihmer Z.: Natural health products, dietary minerals and over-the-counter medications as add-on therapies to antidepressants in the treatment of major depressive disorder: a review., Pubmed, 2019 | Pogany, L; Lazary,J.: Pharmacological treatment and health control beliefs from the perspective of psychiatric patients: differences in attitudes, pubmed, 2019 | Pogany,L, Lazary J.: Health control beliefs and chronic illness: how do they relate?., Pubmed, 2020 | Lazary,J. Elemery, M., Döme,P., Tombor L., Faludi G.: Perifériás szérum endocannabinoid szint változás rTMS kezelés hatására major depressziós zavarnam szenvedők körében, Psychiatria Hungarica Magyar Pszichiátriai Társaság XXIII. jubileumi vándorgyűlés előadás kivonatok Budapest, 2020-01.22-25. 91.oldal, 2020 | PoganyL., Lazary, J.: Health locus of control influence the drug attitude in different way in psychiatric and non-psychiatric samples., 33rd ECNP congress, 12-15. September, virtual congress, 2020 | Lazary, J. Miezah, D., Moustafa, A., Kéri, Sz.: Peripheral biomarkers in major depressiove disorders, Recent topics on major depressive disorders chapter 1 (edited by Ahmed Moustafa), published by Elsevier), 2020 | Lazáry Judit: Stress, inflammation and depression: integrative role of endocannbinoid pathway, Journal of European Psychiatry, supplement of 28th congress of EPA, 2018 | Lazary Judit: Highlights of peripheral biomarkers in major depressive disorder: focus on HPA-axis, inflammation and neurotrophic factors, Neuropsychopharmacologia Hungarica, 2018 | Dome P, Tombor L, Lazary J, Gonda X, Rihmer Z.: Natural health products, dietary minerals and over-the-counter medications as add-on therapies to antidepressants in the treatment of major depressive disorder: a review., Brain Research Bulletin, 2019 | Pogany, L; Lazary,J.: Pharmacological treatment and health control beliefs from the perspective of psychiatric patients: differences in attitudes, Neuropsychopharmacologia Hungarica, 2019 | Pogany,L, Lazary J.: Health control beliefs and chronic illness: how do they relate?., Neuropsychiatria Hungarica, 2020 | Lazary Judit, Eleméry Mónika, Döme Péter, Kiss Szilvia, Gonda Xenia, Tombor László, Pogány László, Becskereki Gergely, Tóth Blanka, Faludi Gábor: Peripheral endocannabinoid serum level in association with repetitive transcranial magnetic stimulation (rTMS) treatment in patients with major depressive disorder, Scientific Reports, 2021 | Pogány László, De Las Cuevas, Lazáry Judit: Validation and analysis of the Patient's Health Belief Questionnaire on Psychiatric Treatment in a sample of Hungarian psychiatric patients, Neuropsychopharmacologia Hungarica, 2021 | Pogány László, Lazáry Judit: Health Control Beliefs and Attitude Toward Treatment in Psychiatric and Non-Psychiatric Clinical Samples, Frontiers in Psychiatry, 2021 | Lazáry Judit, Eszlári Nóra, Krikó Eszter, Tőzsér Dóra, Döme Péter, William J. Deakin, Juhász Gabriella, Bagdy György: Genetic analyses of the endocannabinoid pathway in association with affective phenotypic variants, Neuroscience Letters, 2021 | Lazáry Judit: Symptom improvement is associated with serum cytokine level change during rTMS tretament in patients with treatment resistant depression, Journal of European Psychiatry, supplement of 29th EPA congress, 2021, 2021 | Lazáry Judit: Acute effects of the first period of COVID-19 pandemic on mental state, Neuropsychopharmacologia Hungarica, 2020 | Pogány László, Horváth András Áron, Slezák Adrienn, Rózsavölgyi Éva, Lazáry Judit: The first lockdown due to COVID-19 pandemic from the psychiatric patients' perspective: an ambulatory care client experience survey, Neuropsychopharmacologia Hungarica, 2020 | Pogány László, Lazáry Judit: Emergency state in COVID-19 pandemic: Hungarian patients’ experiences, Supplement of the 29th EPA congress, 2021 | Volz HP, Bartečků E, Bartova L, Bessa J, De Berardis D, Dragasek J, Kozhuharov H, Ladea M, Lazáry J, Roca M, Usov G, Wichniak A, Godman B, Kasper S.: Sick leave duration as a potential marker of functionality and disease severity in depression, Int J Psychiatry Clin Pract, 2022 | Judit Lazáry, Monika Elemery, Szilvia Kiss, László Pogany, Gabor Faludi: What is the link between the antidepressants, the transcranial magnetic stimulation and the peripheral vascular endothelial growth factor?, Abstracts of the 30th Congress of the European Psychiatric Assocation, 2022 | de Leon J, Schoretsanitis G, Smith RL, Molden E, Solismaa A, Seppälä N, Kopeček M, Švancer P, Olmos I, Ricciardi C, Iglesias-Garcia C, Iglesias-Alonso A, Spina E, Ruan CJ, Wang CY, Wang G, Tang YL, Lin SK, Lane HY, Kim YS, Kim SH, Rajkumar AP, González-Esquivel DF, Jung-Cook H, Baptista T, Rohde C, Nielsen J, Verdoux H, Quiles C, Sanz EJ, De Las Cuevas C, Cohen D, Schulte PFJ, Ertuğrul A, Anıl Yağcıoğlu AE, Chopra N, McCollum B, Shelton C, Cotes RO, Kaithi AR, Kane JM, Farooq S, Ng CH, Bilbily J, Hiemke C, López-Jaramillo C, McGrane I, Lana F, Eap CB, Arrojo-Romero M, Rădulescu FŞ, Seifritz E, Every-Palmer S, Bousman CA, Bebawi E, Bhattacharya R, Kelly DL, Otsuka Y, Lazary J, Torres R, Yecora A, Motuca M, Chan SKW, Zolezzi M, Ouanes S, De Berardis D, Grover S, Procyshyn RM, Adebayo RA, Kirilochev OO, Soloviev A, Fountoulakis KN, Wilkowska A, Cubała WJ, Ayub M, Silva A, Bonelli RM, Villagrán-Moreno JM, Crespo-Facorro B, Temmingh H, Decloedt E, Pedro MR, Takeuchi H, Tsukahara M, Gründer G, Sagud M, Celofiga A, Ignjatovic Ristic D, Ortiz BB, Elkis H, Pacheco Palha AJ, LLerena A, Fernandez-Egea E, Siskind D, Weizman A, Masmoudi R, Mohd Saffian S, Leung JG, Buckley PF, Marder SR, Citrome L, Freudenreich O, Correll CU, Müller DJ.: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels, Pharmacopsychiatry, 2021 | Pogány László, Lazáry Judit: Health Control Beliefs and Attitude Toward Treatment in Psychiatric and Non-Psychiatric Clinical Samples, Frontiers in Psychiatry, 2021 | Monika Elemery, Szilvia Kiss, Peter Dome, Laszlo Pogany, Gabor Faludi, Judit Lazary: Change of Circulating Vascular Endothelial Growth Factor Level and Reduction of Anhedonia Are Associated in Patients With Major Depressive Disorder Treated With Repetitiv, Frontiers in Psychiatry, 2022 | Laszlo Pogany, Andras A. Horvath, Judit Lazary: CAN WE INFLUENCE THE NEGATIVE DRUG ATTITUDE? INTERPRETATION OF THE REJECTION OF COVID-19 VACCINE IN THE LIGHT OF RESULTS OF A PILOT STUDY, Ideggyógyászati Szemle, 2022 | Lazary Judit, Eleméry Mónika, Döme Péter, Kiss Szilvia, Gonda Xenia, Tombor László, Pogány László, Becskereki Gergely, Tóth Blanka, Faludi Gábor: Peripheral endocannabinoid serum level in association with repetitive transcranial magnetic stimulation (rTMS) treatment in patients with major depressive disorder, Scientific Reports, 2021 | Pogány László, Lazáry Judit: Health Control Beliefs and Attitude Toward Treatment in Psychiatric and Non-Psychiatric Clinical Samples, Frontiers in Psychiatry, 2021 | Laszlo Pogany, Andras A. Horvath, Judit Lazary: CAN WE INFLUENCE THE NEGATIVE DRUG ATTITUDE? INTERPRETATION OF THE REJECTION OF COVID-19 VACCINE IN THE LIGHT OF RESULTS OF A PILOT STUDY, Ideggyógyászati Szemle, 2022 | Lazáry Judit, Eszlári Nóra, Krikó Eszter, Tőzsér Dóra, Döme Péter, William J. Deakin, Juhász Gabriella, Bagdy György: Genetic analyses of the endocannabinoid pathway in association with affective phenotypic variants, Neuroscience Letters, 2021 |
|
|
|
|
|
|
vissza »
|
|
|